Merck KEYTRUDA gets USFDA priority review for its Second Application Medical Dialogues Bureau9 April 2020 3:30 AM GMTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted and...
